Clinical Trial Update: Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

Phase 1 trial in advanced non-small cell lung cancer evaluating hydroxychloroquine with or without erlotinib was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2013-07-31